600771.SS SHH
GuangYuYuan Chinese Herbal Medicine Co., Ltd.
1W: +0.7%
1M: +2.5%
3M: +1.9%
YTD: -22.1%
1Y: -32.8%
3Y: -56.1%
5Y: -32.2%
¥14.15 ($2.11)
+0.26 (+1.87%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.2B
-4.9% ▼
5Y CAGR: +0.1%
Gross Profit
$891M
-4.5% ▼
5Y CAGR: -1.2%
Operating Income
$91M
-20.9% ▼
5Y CAGR: -8.3%
Net Income
$74M
-17.3% ▼
5Y CAGR: -10.6%
EPS (Diluted)
$0.15
-16.7% ▼
5Y CAGR: -10.8%
EBITDA
$133M
-12.5% ▼
5Y CAGR: -8.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $854M | $1.1B | $1.3B | $1.2B |
| YoY Growth | -8.8% | -23.0% | +32.4% | +13.6% | -4.9% |
| Cost of Revenue | $326M | $333M | $405M | $351M | $330M |
| Gross Profit | $783M | $521M | $726M | $933M | $891M |
| Gross Margin | 70.6% | 61.0% | 64.2% | 72.7% | 73.0% |
| R&D Expenses | $43M | $25M | $29M | $31M | $39M |
| SG&A Expenses | $656M | $864M | $880M | $733M | $662M |
| Operating Expenses | $784M | $892M | $999M | $818M | $801M |
| Operating Income | -$299K | -$371M | -$273M | $115M | $91M |
| Operating Margin | -0.0% | -43.4% | -24.2% | 8.9% | 7.4% |
| Interest Expense | $30M | $31M | $21M | $151K | $8M |
| Income Before Tax | $18M | -$353M | -$265M | $100M | $81M |
| Tax Expense | -$12M | -$20M | -$2M | $8M | -$3M |
| Net Income | $32M | -$316M | -$250M | $90M | $74M |
| Net Margin | 2.9% | -37.0% | -22.1% | 7.0% | 6.1% |
| EPS (Diluted) | $0.07 | $-0.65 | $-0.51 | $0.18 | $0.15 |
| EBITDA | $48M | -$324M | -$188M | $152M | $133M |
| Shares Outstanding | 489M | 489M | 489M | 500M | 496M |